A Trial of Grazax in Subjects With Hayfever
NCT00421655
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
329
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergy
Interventions
DRUG:
Grazax
Sponsor
ALK-Abelló A/S